Cargando…

Herpes simplex virus-1 encephalitis secondary to whole brain radiation therapy for metastatic renal cell carcinoma

Herpes simplex virus-1 (HSV-1) infection is the most common cause of encephalitis. This virus commonly lays dormant in neural ganglia, specifically the trigeminal ganglia, following retrograde axonal transport from the site of infection. States of immunosuppression can activate the virus to cause ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Waack, Andrew, Jaggernauth, Sarah, Iordanou, James, Vattipally, Venkatramana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539624/
https://www.ncbi.nlm.nih.gov/pubmed/36212758
http://dx.doi.org/10.1016/j.radcr.2022.09.018
_version_ 1784803529534210048
author Waack, Andrew
Jaggernauth, Sarah
Iordanou, James
Vattipally, Venkatramana
author_facet Waack, Andrew
Jaggernauth, Sarah
Iordanou, James
Vattipally, Venkatramana
author_sort Waack, Andrew
collection PubMed
description Herpes simplex virus-1 (HSV-1) infection is the most common cause of encephalitis. This virus commonly lays dormant in neural ganglia, specifically the trigeminal ganglia, following retrograde axonal transport from the site of infection. States of immunosuppression can activate the virus to cause active infection. There are several causes of immunosuppression that can cause viral reactivation. Sporadic case reports have demonstrated HSV-1 encephalitis following brain radiotherapy, although no clear relationship between this treatment and HSV-1 encephalitis has been elucidated. HSV1 encephalitis that arises during immunocompromized states has an atypical presentation for encephalitis, potentially obfuscating the diagnosis and delaying subsequent treatment. The main diagnostic criteria, including CSF analysis, brain imaging, and clinical presentation, all commonly present atypically during states of immunosuppression. For these reasons, it is imperative for physicians to be aware of this rare sequelae in appropriate populations, such as patients undergoing brain radiotherapy. We present a case of an atypical presentation of HSV-1 encephalitis in a patient who recently completed radiotherapy for brain metastases secondary to renal cell carcinoma.
format Online
Article
Text
id pubmed-9539624
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95396242022-10-08 Herpes simplex virus-1 encephalitis secondary to whole brain radiation therapy for metastatic renal cell carcinoma Waack, Andrew Jaggernauth, Sarah Iordanou, James Vattipally, Venkatramana Radiol Case Rep Case Report Herpes simplex virus-1 (HSV-1) infection is the most common cause of encephalitis. This virus commonly lays dormant in neural ganglia, specifically the trigeminal ganglia, following retrograde axonal transport from the site of infection. States of immunosuppression can activate the virus to cause active infection. There are several causes of immunosuppression that can cause viral reactivation. Sporadic case reports have demonstrated HSV-1 encephalitis following brain radiotherapy, although no clear relationship between this treatment and HSV-1 encephalitis has been elucidated. HSV1 encephalitis that arises during immunocompromized states has an atypical presentation for encephalitis, potentially obfuscating the diagnosis and delaying subsequent treatment. The main diagnostic criteria, including CSF analysis, brain imaging, and clinical presentation, all commonly present atypically during states of immunosuppression. For these reasons, it is imperative for physicians to be aware of this rare sequelae in appropriate populations, such as patients undergoing brain radiotherapy. We present a case of an atypical presentation of HSV-1 encephalitis in a patient who recently completed radiotherapy for brain metastases secondary to renal cell carcinoma. Elsevier 2022-10-04 /pmc/articles/PMC9539624/ /pubmed/36212758 http://dx.doi.org/10.1016/j.radcr.2022.09.018 Text en © 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Waack, Andrew
Jaggernauth, Sarah
Iordanou, James
Vattipally, Venkatramana
Herpes simplex virus-1 encephalitis secondary to whole brain radiation therapy for metastatic renal cell carcinoma
title Herpes simplex virus-1 encephalitis secondary to whole brain radiation therapy for metastatic renal cell carcinoma
title_full Herpes simplex virus-1 encephalitis secondary to whole brain radiation therapy for metastatic renal cell carcinoma
title_fullStr Herpes simplex virus-1 encephalitis secondary to whole brain radiation therapy for metastatic renal cell carcinoma
title_full_unstemmed Herpes simplex virus-1 encephalitis secondary to whole brain radiation therapy for metastatic renal cell carcinoma
title_short Herpes simplex virus-1 encephalitis secondary to whole brain radiation therapy for metastatic renal cell carcinoma
title_sort herpes simplex virus-1 encephalitis secondary to whole brain radiation therapy for metastatic renal cell carcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539624/
https://www.ncbi.nlm.nih.gov/pubmed/36212758
http://dx.doi.org/10.1016/j.radcr.2022.09.018
work_keys_str_mv AT waackandrew herpessimplexvirus1encephalitissecondarytowholebrainradiationtherapyformetastaticrenalcellcarcinoma
AT jaggernauthsarah herpessimplexvirus1encephalitissecondarytowholebrainradiationtherapyformetastaticrenalcellcarcinoma
AT iordanoujames herpessimplexvirus1encephalitissecondarytowholebrainradiationtherapyformetastaticrenalcellcarcinoma
AT vattipallyvenkatramana herpessimplexvirus1encephalitissecondarytowholebrainradiationtherapyformetastaticrenalcellcarcinoma